"covid-19" MAB sponsorship prototype
Ended Other Transaction Agreement Awarded Last action
- Contract number
- W911QY2190008
- Awardee
-
Resilience Government Services, Inc. UEI GC2RFAZK8G64
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $31,048,125
Award facts
- Contract value 50% obligated
- $62,096,250.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Other
- Place of performance
- Santa Fe, FL 32615, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$21,043,184 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $163,125 | |
| Supplemental Agreement for work within scope | $1,622,200 | |
| Supplemental Agreement for work within scope | $14,347,960 | |
| Other Administrative Action | $0 | |
| Original award | $35,958,024 |
Show all 12
About this award
This federal contract award, W911QY2190008, was issued by the Joint PEO Chemical and Biological Defense, a subcomponent of the U.S. Department of the Army, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $62,096,250.00 Other Transaction Agreement is for the development of a "COVID-19" Monoclonal Antibody (MAB) Sponsorship Prototype. Resilience Government Services, a technology-focused biomanufacturing company, has previously received federal contracts and task orders from the Department of Defense and Department of Health and Human Services for medical countermeasure development, including clinical trials and regulatory approval processes. This award does not have a set-aside designation and is scheduled for completion by September 29, 2026.
Quick answers
Who was awarded contract W911QY2190008?
W911QY2190008 was awarded to Resilience Government Services, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on November 10, 2020.
How much is contract W911QY2190008 worth?
The government has obligated $31,048,125 on W911QY2190008. Its current value, with exercised options, is $62,096,250.
Which agency awarded contract W911QY2190008?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY2190008, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY2190008 competed?
The extent of competition for W911QY2190008 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award